/** MDX blogpost not generated because the required schema for blogpostSummary is a string; content is therefore provided as a single Markdown string. */

Centum Electronics Q1 FY27: A softer quarter, but order book strength stays intact

Centum Electronics began FY27 with steady top-line growth but a weaker margin profile, largely due to execution phasing in its higher-margin Build-to-Specification (BTS) business. On a stand-alone basis, revenue from operations in Q1 FY27 was INR 2,048 million, up 10.7% year on year. EBITDA came in at INR 231 million with an EBITDA margin of 11.28%, while profit after tax was INR 135 million with a PAT margin of 6.59%.

Management highlighted that the quarter was muted versus full-year expectations because of quarterly variation in project execution, especially within BTS. The company reiterated that performance should be assessed on a full-year basis, given the lumpy nature of defence and strategic programs.

A key non-operational development during the quarter was the completion of a major overseas restructuring. Centum’s overseas entities in France, which had entered court-led proceedings in FY26, were deconsolidated effective 4 June 2026 after the French court approved the transfer of substantially all operating businesses and employees to successful bidders. The investor presentation states a profit on deconsolidation of INR 943 million. This one-time item materially impacted consolidated profitability in Q1 FY27.

Q1 FY27 performance in context

Centum operates with two complementary business engines. Electronic Manufacturing Services (EMS) is positioned as the cash engine with shorter working capital cycles and benchmark margins around 9% to 10%. BTS is positioned as the value engine, targeting 20% plus benchmark margins but requiring much longer working capital cycles and longer project execution timelines.

The company’s stand-alone revenue mix in Q1 FY27 was EMS at INR 1,482 million and BTS at INR 566 million. Over the longer term, Centum has described this dual model as a way to balance profitability, working capital, and long-term value creation.

A key positive for the quarter was visibility. Centum closed Q1 FY27 with a stand-alone order book of about INR 17,972 million, up 31% year on year. The order book mix was BTS INR 9,254 million and EMS INR 8,718 million. The company also highlighted that BTS order book is typically executed over 25 to 30 months, while EMS is usually executed over 9 to 12 months.

Financial snapshot

The key operational takeaway was margin compression. Expenses grew faster than revenue year on year, and management linked the weaker margin to a lower BTS contribution during the quarter.

Segment momentum: BTS order book and EMS ramp-up

In BTS, management stated the order book increased about 40% year on year, supported by demand in defence and strategic programs. The company noted continued order wins for complex payload electronics for ISRO programs and stated that BTS revenue contribution was lower in the quarter but expected to accelerate in subsequent quarters.

In EMS, Centum reported 20% year-on-year revenue growth in Q1 FY27 and a 23% year-on-year increase in the EMS order book, supported by a ramp-up with global semiconductor equipment customers and continued momentum in industrial segments.

One EMS area repeatedly emphasised in the concall was semiconductor equipment manufacturing. Management explained that this business sits within EMS and covers box builds and PCBAs used in semiconductor manufacturing equipment. The company stated that revenue from this segment was practically zero in FY25, exceeded INR 100 crore in FY26, and is expected to more than double over the next one to two years. Management also clarified that margins remain in the EMS band of around 10% to 11% EBITDA, given the cost-plus nature of the model.

The overseas restructuring impact: clarity returns to continuing operations

A major development was the deconsolidation of Centum’s overseas subsidiaries in France. The investor presentation outlines that court-led proceedings were initiated in FY26, bids were received, and the transfer of substantially all operating businesses and employees was approved on 4 June 2026. After this transfer, the entities ceased operating activities and were deconsolidated under Ind-AS 110.

The court subsequently moved the matter to liquidation proceedings and appointed a judicial liquidator on 2 July 2026. Management stated on the concall that, with the operating businesses transferred and the restructuring process substantially completed, it does not expect further liabilities from these subsidiaries.

This event created a sharp divergence between consolidated and stand-alone profitability in Q1 FY27. Consolidated PAT was INR 1,055 million, driven by the one-time deconsolidation profit, while profit from continuing operations after tax was INR 112 million.

Geography and vertical mix

Centum provided a stand-alone revenue breakup by geography for Q1 FY27: India contributed 46%, Europe and UK 23%, and North America and rest of world 31%.

The company also disclosed a vertical mix for Q1 FY27 stand-alone revenues: defence, space and aerospace 45%, semiconductor 17%, healthcare 14%, transportation and automotive 12%, and industry and energy 12%.

On the order book side, the geographic split was more tilted to India: India 54%, Europe and UK 33%, and North America and rest of world 13%.

What management guided for FY27 and beyond

Management maintained guidance visibility of about 25% revenue growth for FY27 and stated similar visibility for FY28, based on the current order book and pipeline. On profitability, the CFO stated the company is aiming to move EBITDA margins up and above about 13%, compared with about 12.5% reported last year, though he noted it is too early to comment definitively on next year.

On exports, management said the export contribution should remain in the 50% to 55% range or slightly higher, supported by expected growth in EMS.

Key takeaways

Centum’s Q1 FY27 numbers reflect a softer quarter on margins, but the underlying visibility improved with a strong order book and continued momentum in EMS. The completion of the overseas restructuring removes a long-running overhang and improves transparency around continuing operations, though it also introduces one-time accounting noise in consolidated earnings.

The near-term investor focus is likely to remain on two factors that management repeatedly flagged: improved BTS execution and revenue phasing over the next quarters, and sustained ramp-up in EMS programs such as semiconductor equipment and industrial electrification. Management continues to position the company as a high reliability electronics partner, with long customer relationships and increasing opportunities across strategic sectors.